We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+39.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.3M
AUM Growth
+$310K
Cap. Flow
-$20K
Cap. Flow %
-0.14%
Top 10 Hldgs %
65.27%
Holding
116
New
18
Increased
Reduced
9
Closed
11

Sector Composition

Rank Sector Weight
1 Financials 21.24%
2 Energy 13.36%
3 Consumer Discretionary 13.01%
4 Materials 11.61%
5 Technology 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVBG
76
DELISTED
Everbridge, Inc. Common Stock
EVBG
$29.6K 0.21%
+853
New +$27.3K
PEGA icon
77
Pegasystems
PEGA
$5.11B
$29.1K 0.2%
+1,200
New +$25.3K
GLP icon
78
Global Partners
GLP
$1.67B
$28.8K 0.2%
+930
New +$31.4K
HALO icon
79
Halozyme
HALO
$9.92B
$28.6K 0.2%
750
PEN icon
80
Penumbra
PEN
$12.6B
$28.4K 0.2%
102
TEX icon
81
Terex
TEX
$7.59B
$28K 0.2%
578
ENSG icon
82
The Ensign Group
ENSG
$10.6B
$27.2K 0.19%
285
UFPI icon
83
UFP Industries
UFPI
$5.01B
$27K 0.19%
340
CVLT icon
84
Commault Systems
CVLT
$5.06B
$27K 0.19%
476
INSP icon
85
Inspire Medical Systems
INSP
$1.49B
$26.9K 0.19%
115
OVV icon
86
Ovintiv
OVV
$16.8B
$26.1K 0.18%
723
-365
-34% -$16.1K
SUPN icon
87
Supernus Pharmaceuticals
SUPN
$2.71B
$25.9K 0.18%
+714
New +$27.5K
ESTA icon
88
Establishment Labs
ESTA
$2.75B
$25.3K 0.18%
373
CUTR
89
DELISTED
Cutera, Inc.
CUTR
$24.9K 0.17%
1,053
AXNX
90
DELISTED
Axonics, Inc. Common Stock
AXNX
$24.6K 0.17%
451
BCSF icon
91
Bain Capital Specialty
BCSF
$825M
$23.5K 0.16%
+1,971
New +$25.2K
BPMC
92
DELISTED
Blueprint Medicines
BPMC
$23.3K 0.16%
518
KROS icon
93
Keros Therapeutics
KROS
$199M
$22.8K 0.16%
535
NARI
94
DELISTED
Inari Medical, Inc. Common Stock
NARI
$22.5K 0.16%
365
DDS icon
95
Dillards
DDS
$9.26B
$22.5K 0.16%
73
-62
-46% -$22K
VCYT icon
96
Veracyte
VCYT
$4.5B
$22.3K 0.16%
+1,001
New +$24.2K
PLAY icon
97
Dave & Buster's
PLAY
$365M
$22.2K 0.16%
+603
New +$24.1K
STRO icon
98
Sutro Biopharma
STRO
$391M
$20.4K 0.14%
+441
New +$28K
CCRN
99
DELISTED
Cross Country Healthcare
CCRN
$19.8K 0.14%
888
ICPT
100
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$19.6K 0.14%
+1,459
New +$25.2K

Similar funds

Virtus Fund Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, Virtus Fund Advisers held 116 positions worth $14.3M, up 2.2% from $13.9M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Virtus Fund Advisers's Q1 2023 filing shows 18 new, 9 reduced and 11 closed positions. Its largest new stake was Intapp: 3,207 shares worth $144K. The largest sale was Balchem Corp, an estimated $70.6K.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Energy and Consumer Discretionary.

  • Virtus Fund Advisers's largest Q1 2023 buy was Intapp: 3,207 shares worth $144K.
  • Virtus Fund Advisers's biggest Q1 2023 reduction was Commercial Metals, cutting an estimated $58.4K.
  • Virtus Fund Advisers fully exited Balchem Corp in Q1 2023, selling an estimated $70.6K.
  • Virtus Fund Advisers's ten largest holdings make up 65% of its $14.3M portfolio in Q1 2023.
  • Virtus Fund Advisers opened 18 new positions and closed 11 in Q1 2023.
  • Virtus Fund Advisers's portfolio value rose 2.2% quarter-over-quarter to $14.3M.

Based on Virtus Fund Advisers's 13F filing for Q1 2023, filed 15 May 2023.